Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pulmonx (LUNG) Other financing activities (2019 - 2025)

Pulmonx has reported Other financing activities over the past 5 years, most recently at $23000.0 for Q3 2025.

  • Quarterly Other financing activities changed N/A to $23000.0 in Q3 2025 from the year-ago period, while the trailing twelve-month figure was $76000.0 through Sep 2025, up 43.4% year-over-year, with the annual reading at $53000.0 for FY2022, 29.27% up from the prior year.
  • Other financing activities was $23000.0 for Q3 2025 at Pulmonx, down from $53000.0 in the prior quarter.
  • Over five years, Other financing activities peaked at $100000.0 in Q1 2021 and troughed at -$59000.0 in Q2 2021.
  • The 3-year median for Other financing activities is $38000.0 (2022), against an average of $29250.0.
  • The largest YoY upside for Other financing activities was 21.95% in 2021 against a maximum downside of 195.16% in 2021.
  • A 3-year view of Other financing activities shows it stood at -$59000.0 in 2021, then skyrocketed by 189.83% to $53000.0 in 2022, then tumbled by 56.6% to $23000.0 in 2025.
  • Per Business Quant, the three most recent readings for LUNG's Other financing activities are $23000.0 (Q3 2025), $53000.0 (Q4 2022), and -$59000.0 (Q2 2021).